Preferred Label : olutasidenib;

Obsolete resource : false;

UNII : 0T4IMT8S5Z;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/rezlidhia
2025
false
false
false
France
French
drug information
olutasidenib
olutasidenib
leukemia, myeloid, acute
Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
adult
leukemia, myeloid, acute
IDH1 Gene Mutation
IDH1 inhibitor
summary of product characteristics

---
https://www.has-sante.fr/jcms/p_3468410/fr/olutasidenib-pharma-blue-leucemie-aigue-myeloide
2023
false
false
false
France
treatment outcome
adult
Recurrent Adult Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
IDH1 protein, human
mutation
leukemia, myeloid, acute
olutasidenib
evaluation of the transparency committee
leukemia, myeloid, acute
olutasidenib

---
Nous contacter.
07/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.